Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Smyth

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Human Mutation|June 30, 2000
The spectrum of patched mutations in a collection of Australian basal cell carcinomasT Evans, W Boonchai, S Shanley, et al.
Human Molecular Genetics|February 5, 1999
Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32I Smyth, M A Narang, T Evans, et al.
American Journal of Human Genetics|January 1, 1997
Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evidentC Wicking, S Shanley, I Smyth, et al.
Cell|June 14, 1996
Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndromeH Hahn, C Wicking, P G Zaphiropoulous, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Human Mutation|June 30, 2000
The spectrum of patched mutations in a collection of Australian basal cell carcinomasT Evans, W Boonchai, S Shanley, et al.
Human Molecular Genetics|February 5, 1999
Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32I Smyth, M A Narang, T Evans, et al.
American Journal of Human Genetics|January 1, 1997
Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evidentC Wicking, S Shanley, I Smyth, et al.
Cell|June 14, 1996
Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndromeH Hahn, C Wicking, P G Zaphiropoulous, et al.
Pageof 2